, and Ming Liu 1, 2, * SI Tables   Table S1. 13 C NMR data for compounds 1-5 (recorded in CDCl 3 ) 112.4, C 112.6, C 112.6, C 112.5, C 112.5, C 2' 150.5, C 150.5, C 150.5, C 150.5, C 150.5, C 3' 128.3, C 128.0, C 128.0, C 128.3, C 128.3, C 4' 124.1, CH 124.4, CH 124.4, CH 124.1, CH 124.1, CH 5' 118.9, CH 119.0, CH 119.0, CH 119.0, CH 119.0, CH 6' 119.6, CH 120.0, CH 120.0, CH 119.7, CH 119.7, CH 7' 169.5, C 169.3, C 169.3, C 169.4, C 169.4, C 8' 168.7, C 168.4, C 168.4, C 168.7, C 168.7, C 9' 24.9, CH 3 Cells were treated with these drugs for 72 h, and the inhibition rates were assayed by MTT methods. Fig. S1 . NADA does not decrease the mRNA level of E6/E7. HeLa cells were treated with NADA (0-0.1 M) for 24 h and HPV16 E6/E7 mRNA levels were measured by qPCR. qPCR reactions were performed by the ABI7500 system (Applied Biosystems, CA, USA) and SYBR green dye (Roche, Basle, Switzerland). The primer sequences were as follows: 5'-CAGGGCTGCTTTTAACTCTGGT-3'(forward) and 5'-CCTGGAAGATGGTGATGGGAT-3'(reverse) for GAPDH; 5'-CACAGGAGCGACCCAGAAAG-3'(forward) and 5'-GCATAAATCCCGAAAAGCAAAG -3'(reverse) for E6; 5'-CAGAGGAGGAGGATGAAATAGATG-3'(forward) and 5'-GCACAACCGAAGCGTAGAGTC-3'(reverse) for E7. Data represent means ± SD of relative mRNA expression to the untreated cells. Figure 8e using gray analysis method. Values represent the means ± SD. * P < 0.05, ** P < 0.01 versus the NADA group. Fig. S4 . To confirm the specificity effect on HPV oncoprotiens, we silenced HPV18 E6 in HeLa and examined its sensitivity to NADA. The results showed that HPV-18 E6 siRNA (si18E6) could markedly downregulate E6 expression (a, b). The IC 50 value of NADA against this E6 low expressing HeLa cells were much larger than the wild-type HeLa cells, indicating HPV oncoprotiens downregulation could reduced the sensitivity of HeLa cells to NADA.
(a) si18E6 downregulates the expression of E6. Cells were seeded into 6-well plates and reached 70% confluency before transfection. siRNAs for HPV18 E6, and scramble siRNA (siNC) were complexed with Lipofectamine 3000 (Invitrogen, Shanghai, China) according to the manufacturer's instructions and applied to each well, respectively. The transfection medium was removed and replaced with complete medium after 6 h. Then the expression level of E6 was assessed by western blotting after 24 h. siRNAs were synthesized by GenePharma (Shanghai, China) and the sequences are as follows: si18E6 sense: 5′-CAUUUACCAGCCCGACGAGTT-3′ and antisense:5′-CUCGUCGGGCUGGUAAAUGTT-3′; siNC sense:5′-UUCUCCGAACGUGUACGUdTdT-3′ and antisense: 5′-ACGUGACACGUUCGGAGAAdTdT-3′. 
